FDA Inspection 1264269 — Aprecia Pharmaceuticals, LLC

Aprecia Pharmaceuticals, LLC — FEI 3012061714

The FDA completed an inspection of Aprecia Pharmaceuticals, LLC on March 21, 2025 in Mason, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mason, OH (United States)

Citations

IDCFRDescription
203121 CFR 211.194(a)Complete test data included in records
356721 CFR 211.84(d)(2)Component identification test